You are viewing a single comment's thread.

view the rest of the comments →

letsdothis2 ago

article from 2000: https://siteselection.com/ssinsider/bbdeal/bd000417.htm

The latest expansive move for Baxter's Hyland Immuno unit -- which develops and produces therapeutic proteins to treat hemophilia, immune deficiencies and other blood-related disorders - is unfolding in Thousand Oaks, Calif. Baxter is planning a second and third manufacturing suite at the Thousand Oaks site. Together, the two expansions entail a capital investment of $100 million.